CBSC activates China manufacturing pipeline and advances MyCardia AT into final NMPA submission phase with Ebulent Medical.

Jan 15

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案激活MyCardia AT中国生产流程并进入NMPA最终申报阶段

CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.

Dec 07

Cardiac Biotech

Cardiac Biotech

与深圳邦普医疗系统有限公司签署制造意向书

Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.

How can we help you?

Tell us what you are interested in.

Contact Us

订阅我们的新闻邮件！

订阅我们的电子报，我们将直接向您发送最新消息。